杨锋先生
- 蓝海资本创始合伙人及行政总裁
杨锋先生拥有超过20年股权投资经验，领导投资的医药行业项目总金额超过十亿美元等值。
Prior to founding Blue Ocean Capital Group, Mr. Yang served as Managing Director at CCBI, responsible for principal investments and China’s first institutional healthcare PE fund. Mr. Yang led investments in dozens of pharmaceutical companies including Innorna, Cure Genetics, Koka Lifesciences, InterHill MED, HighTide Therapeutics, Boan Biotech, Ribo Life Sciences and Signet Therapeutics, among some of which he served as a board member.
杨锋先生是香港生物医药创新协会会董、香港中国金融协会理事、香港创业及私募投资协会理事和香港科技大学大商学院顾问委员会理事。杨锋先生是香港中文大学博士生，拥有香港科技大学商学院MBA学位。